Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Artificial Intelligent Prognostic Assessment and Pathological Basis Research of Early Primary Hepatocellular Carcinoma After Minimally Invasive Treatment Based on Multimodal MRI and Clinical Big Data

NCT04299919 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Dalian Medical University as lead sponsor.

NCT NCT04299919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04299919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Artificial Intelligent Prognostic Assessment and Pathological Basis Research of Early Primary Hepatocellular Carcinoma After Minimally Invasive Treatment Based on Multimodal MRI and Clinical Big Data
Lead sponsor
The First Affiliated Hospital of Dalian Medical University
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2007
Completion date
June 30, 2024
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma